CoChat

The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade

Open access
Ribas, Antoni, Tumeh, Paul C. · 2014 · Clinical Cancer Research
Cited by 88

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

It is conceivable that, in the near future, an assay that defines the likelihood of a patient with advanced cancer to respond to immunotherapy based on PD1/L1 blockade will be the initial decision point to select the treatment of patients with any cancer type. Clin Cancer Res; 20(19); 4982–4. ©2014 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-14-0933

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 88

Metadata

Authors
Ribas, A., & Tumeh, P. C.
Venue
Clinical Cancer Research
Published
2014-09-30
Volume
20
Issue
19
Pages
4982-4984
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2164842455
Cited by
88
References
4
FWCI
6.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-14-0933
The paper
Ribas, A., & Tumeh, P. C. (2014). The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-14-0933

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.